These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9364136)
1. The current status of acellular pertussis vaccines. Corbel MJ; Xing DK J Med Microbiol; 1997 Oct; 46(10):817-8. PubMed ID: 9364136 [No Abstract] [Full Text] [Related]
2. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950 [TBL] [Abstract][Full Text] [Related]
3. Pertussis cocoon strategy: would it be useful for Latin America and other developing countries? Ulloa-Gutierrez R; Gentile A; Avila-Aguero ML Expert Rev Vaccines; 2012 Dec; 11(12):1393-6. PubMed ID: 23252382 [No Abstract] [Full Text] [Related]
4. Acellular pertussis vaccines in China. Wang L; Lei D; Zhang S Vaccine; 2012 Nov; 30(50):7174-8. PubMed ID: 23084855 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522 [TBL] [Abstract][Full Text] [Related]
10. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations. Gardner P Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031 [TBL] [Abstract][Full Text] [Related]
11. Pertussis vaccination and whooping cough: and now what? Guiso N Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131 [TBL] [Abstract][Full Text] [Related]
12. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
14. [Pertussis: current epidemiology and recommendations of the Health Council with regard to vaccination policy]. van Wijngaarden JK; Huisman J; van der Meer JW; Visser HK Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2297-301. PubMed ID: 11143295 [TBL] [Abstract][Full Text] [Related]
15. Has the change to acellular pertussis vaccine improved or worsened pertussis control? Halperin SA; De Serres G CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952 [No Abstract] [Full Text] [Related]
16. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705 [TBL] [Abstract][Full Text] [Related]
17. Shortcomings of pertussis vaccines: why we need a third generation vaccine. Poolman JT Expert Rev Vaccines; 2014 Oct; 13(10):1159-62. PubMed ID: 25089373 [TBL] [Abstract][Full Text] [Related]
19. Pertussis immunization--current knowledge and recommendations. Ross E Health Visit; 1982 Dec; 55(12):648-53. PubMed ID: 6925569 [No Abstract] [Full Text] [Related]
20. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients. Isomura S; Suzuki S; Sato Y Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]